Tony Peled

922 total citations
19 papers, 370 citations indexed

About

Tony Peled is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, Tony Peled has authored 19 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 7 papers in Oncology and 5 papers in Hematology. Recurrent topics in Tony Peled's work include Immune Cell Function and Interaction (9 papers), CAR-T cell therapy research (5 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Tony Peled is often cited by papers focused on Immune Cell Function and Interaction (9 papers), CAR-T cell therapy research (5 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Tony Peled collaborates with scholars based in Israel, United States and Netherlands. Tony Peled's co-authors include Eitan Fibach, Eliezer A. Rachmilewitz, Eugenia Prus, Amnon Peled, Arnon Nagler, Efrat Landau, Abraham J. Treves, Hadas Shoham, Batya Lerrer and Haim Cohen and has published in prestigious journals such as Blood, Journal of Cellular Physiology and British Journal of Haematology.

In The Last Decade

Tony Peled

19 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tony Peled Israel	8	183	147	127	108	103	19	370
Shuqian Xu China	10	189 1.0×	148 1.0×	102 0.8×	72 0.7×	35 0.3×	20	381
Laixi Bi China	12	102 0.6×	199 1.4×	38 0.3×	105 1.0×	81 0.8×	15	385
Richard XuFeng United States	6	127 0.7×	214 1.5×	46 0.4×	73 0.7×	57 0.6×	8	349
Yi-Cheng Wang United States	12	288 1.6×	276 1.9×	55 0.4×	50 0.5×	90 0.9×	15	517
Florian Perner Germany	10	238 1.3×	293 2.0×	124 1.0×	46 0.4×	64 0.6×	26	471
Marek Kiełbiński Poland	12	269 1.5×	158 1.1×	61 0.5×	130 1.2×	93 0.9×	23	536
Emanuela Messa Italy	11	456 2.5×	277 1.9×	275 2.2×	44 0.4×	60 0.6×	35	629
Denise Levitan United States	8	229 1.3×	331 2.3×	33 0.3×	38 0.4×	86 0.8×	18	546
Eugenio Lucia Italy	11	125 0.7×	122 0.8×	120 0.9×	48 0.4×	76 0.7×	48	290

Countries citing papers authored by Tony Peled

Since Specialization

Citations

This map shows the geographic impact of Tony Peled's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tony Peled with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tony Peled more than expected).

Fields of papers citing papers by Tony Peled

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tony Peled. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tony Peled. The network helps show where Tony Peled may publish in the future.

Co-authorship network of co-authors of Tony Peled

This figure shows the co-authorship network connecting the top 25 collaborators of Tony Peled. A scholar is included among the top collaborators of Tony Peled based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tony Peled. Tony Peled is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Koning, Coco de, Weiyang Tao, Mitchell E. Horwitz, et al.. (2021). Lymphoid and myeloid immune cell reconstitution after nicotinamide-expanded cord blood transplantation. Bone Marrow Transplantation. 56(11). 2826–2833. 3 indexed citations

Bachanová, Veronika, David H. McKenna, Xianghua Luo, et al.. (2019). Results of a Phase 1 Trial of Gda-201, Nicotinamide-Expanded Allogeneic Natural Killer Cells (NAM-NK) in Patients with Refractory Non-Hodgkin Lymphoma (NHL) and Multiple Myeloma (MM). Blood. 134(Supplement_1). 777–777. 5 indexed citations

Lodie, Tracey, et al.. (2019). Nicotinamide (NAM) Modulates Transcriptional Signature of Ex Vivo Cultured UCB CD34+ Cells (Omidubicel) and Preserves Their Stemness and Engraftment Potential. Blood. 134(Supplement_1). 3718–3718. 1 indexed citations

Bachanová, Veronika, David H. McKenna, Xianghua Luo, et al.. (2019). First-in-Human Phase I Study of Nicotinamide-Expanded Related Donor Natural Killer Cells for the Treatment of Relapsed/Refractory Non-Hodgkin Lymphoma and Multiple Myeloma. Biology of Blood and Marrow Transplantation. 25(3). S175–S176. 12 indexed citations

Peled, Tony, Guy Brachya, Efrat Landau, et al.. (2017). Enhanced In Vivo Persistence and Proliferation of NK Cells Expanded in Culture with the Small Molecule Nicotinamide: Development of a Clinical-Applicable Method for NK Expansion. Blood. 130(Suppl_1). 657–657. 7 indexed citations

Parikh, Suhag, Joel A. Brochstein, Paul L. Martin, et al.. (2016). Successful Engraftment of Donor Umbilical Cord Blood (UCB) Cells after Co-Transplantation of Nicord® (Ex Vivo Expanded UCB Progenitor Cells with Nicotinamide) and a Second Unmanipulated Cord Blood Unit after Myeloablative Chemotherapy in Pediatric Patients with Severe Sickle Cell Disease. Blood. 128(22). 3651–3651. 1 indexed citations

Horwitz, Mitchell E., Patrick J. Stiff, Nelson J. Chao, et al.. (2013). Nicord® Expanded Hematopoietic Progenitor Cells (HPC) Are Capable of Outcompeting the Unmanipulated (UM) Cord Blood Unit and of Prolonged Myeloid and Lymphoid Engraftment Following Myeloablative Dual Umbilical Cord Blood (UCB) Transplantation. Biology of Blood and Marrow Transplantation. 19(2). S118–S118. 1 indexed citations

Berg, Maria, Tony Peled, Robert Reger, et al.. (2013). Improved Homing To Bone Marrow, Spleen and Lung Of Adoptively Infused NK Cells Expanded Ex Vivo With The Small Molecule Nicotinamide Using Feeder-Free Conditions. Blood. 122(21). 897–897. 4 indexed citations

Mamcarz, Ewelina, Maria Berg, Tony Peled, et al.. (2012). Nicotinamide (NAM) Increases Surface Expression of CD62L On in Vitro Expanded NK Cells. Blood. 120(21). 4355–4355. 2 indexed citations

10.

Peled, Tony, Hadas Shoham, Dima Yackoubov, et al.. (2011). Nicotinamide, a SIRT1 inhibitor, inhibits differentiation and facilitates expansion of hematopoietic progenitor cells with enhanced bone marrow homing and engraftment. Experimental Hematology. 40(4). 342–355.e1. 138 indexed citations

11.

Peled, Amnon, et al.. (2011). Nicotinamide, a Form of Vitamin B3, Promotes Expansion of Natural Killer Cells That Display Increased In Vivo Survival and Cytotoxic Activity,. Blood. 118(21). 4035–4035. 15 indexed citations

12.

Peled, Tony, Hadas Shoham, Dima Yackoubov, et al.. (2009). Nicotinamide, a Recognized Inhibitor of SIRT1, Promotes Expansion in Ex Vivo Cultures of Short and Long-Term Repopulating Cells.. Blood. 114(22). 2431–2431. 3 indexed citations

13.

Peled, Tony, et al.. (2006). Antagonists to Retinoid Receptors Down-Regulate CD38 Expression and Inhibit In Vitro Differentiation of Cord Blood Derived CD34+ Cells.. Blood. 108(11). 3652–3652. 1 indexed citations

14.

Peled, Tony, et al.. (2006). Nicotinamide Modulates Ex-Vivo Expansion of Cord Blood Derived CD34+ Cells Cultured with Cytokines and Promotes Their Homing and Engraftment in SCID Mice.. Blood. 108(11). 725–725. 5 indexed citations

15.

Prus, Eugenia, Tony Peled, & Eitan Fibach. (2003). The Effect of Tetraethylenepentamine, a Synthetic Copper Chelating Polyamine, on Expression of CD34 and CD38 Antigens on Normal and Leukemic Hematopoietic Cells. Leukemia & lymphoma. 45(3). 583–589. 8 indexed citations

16.

Peled, Tony, Efrat Landau, Eugenia Prus, Abraham J. Treves, & Eitan Fibach. (2002). Cellular copper content modulates differentiation and self‐renewal in cultures of cord blood‐derived CD34⁺ cells. British Journal of Haematology. 116(3). 655–661. 75 indexed citations

17.

Fibach, Eitan, et al.. (1994). The Effect of Human Myelomonocytic Leukemic Cell Line (M20) Derived IL-1 Inhibitor on Human Erythroid Cell Development. Leukemia & lymphoma. 15(3-4). 327–332. 2 indexed citations

18.

Fibach, Eitan, Tony Peled, & Eliezer A. Rachmilewitz. (1982). Self‐renewal and commitment to differentiation of human leukemic promyelocytic cells (HL‐60). Journal of Cellular Physiology. 113(1). 152–158. 45 indexed citations

19.

Fibach, Eitan, et al.. (1982). Modulation of the maturation of human leukemic promyelocytes (HL-60) to granulocytes or macrophages. Leukemia Research. 6(6). 781–790. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact